Clinical Trials Logo

Prostate Cancer clinical trials

View clinical trials related to Prostate Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05447637 Completed - Prostate Cancer Clinical Trials

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Start date: November 1, 2019
Phase:
Study type: Observational [Patient Registry]

This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.

NCT ID: NCT05423431 Completed - Prostate Cancer Clinical Trials

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Start date: November 9, 2020
Phase:
Study type: Observational

Dosimetry efficacy of the hydrogel spacer.

NCT ID: NCT05399940 Completed - Prostate Cancer Clinical Trials

The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

Purpose: To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis. Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

NCT ID: NCT05354427 Completed - Prostate Cancer Clinical Trials

Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients

CLP-10095
Start date: June 18, 2020
Phase:
Study type: Observational

Assessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.

NCT ID: NCT05323747 Completed - Prostate Cancer Clinical Trials

Prospective Evaluation of a Commercially Available Hydrogel Spacer

BP-008
Start date: November 20, 2020
Phase:
Study type: Observational

Dosimetry efficacy evaluation of the hydrogel spacer

NCT ID: NCT05304169 Completed - Prostate Cancer Clinical Trials

Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.

PRIZE
Start date: November 14, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy, quality of life and safety of switching from monthly (3.6 mg) or quarterly (10.8 mg) goserelin acetate (Zoladex®) to semiannual leuprorelin acetate 45 mg (Eligard® 45 mg) in prostate cancer patients with adequate hormonal castration level (plasma testosterone levels ≤50 ng/dL).

NCT ID: NCT05239377 Completed - Prostate Cancer Clinical Trials

MiProstate - Information Hub for the Prostate Cancer Care Flow

Start date: February 21, 2017
Phase:
Study type: Observational

This is an observational cohort study with a non-concurrent comparison group evaluating the use of a digital decision support tool (MiProstate/ISPM) at pre-prostatectomy, multidisciplinary conferences.

NCT ID: NCT05184725 Completed - Prostate Cancer Clinical Trials

CARINAE for Stress Relief in Perioperative Care

CARINAE
Start date: January 10, 2022
Phase: N/A
Study type: Interventional

Preventing pre-surgical stress can help patients achieve positive outcomes on health and well-being. However, very few patients receive adequate stress relief support prior to a surgical procedure. Provision of education and information about the surgery can be a crucial component of the preoperative experience and is inversely related to levels of preoperative anxiety. However, resource constraints make face-to-face education sessions untenable, given cost considerations and time investment by trained health personnel. Interventions based on mobile health (mHealth) technologies, geared towards increasing familiarity with surgical procedures and hospital environments have been shown to help patients feel informed about possible benefits and risks of available treatment options. mHealth apps and Virtual Reality (VR) can offer patients experience in the perioperative environment that can be helpful in empowering patients and enhancing a more positive experience, while reducing stress. However, available applications focus only on providing informative content, neglecting the importance of patient empowerment with a more robust educational curriculum. According to this, the Software as a Medical Device (SaMD) CARINAE, aims to support patients and caregivers during the whole perioperative process. SaMD CARINAE consists of an mHealth mobile application for patients and caregivers, a Virtual Reality headset for patients, and a web application for healthcare professionals.

NCT ID: NCT05040672 Completed - Prostate Cancer Clinical Trials

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees

LB2008
Start date: June 1, 2021
Phase:
Study type: Observational

Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of a pharmaceutical company.

NCT ID: NCT05022576 Completed - Prostate Cancer Clinical Trials

Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy

Start date: January 30, 2019
Phase: N/A
Study type: Interventional

Gallium-68 prostate-specific-membrane-antigen (Ga-68 PSMA) PET/CT is being used in Prostate cancer imaging. In the present study, we aimed to evaluate the efficacy and safety of robotic arm-assisted Ga-68 PSMA PET/CT-guided transgluteal prostatic biopsy. Seventy-eight participants with a clinical suspicion of PCa were recruited from January 2019 to September 2020. All the patients underwent whole-body Ga-68 PSMA PET/CT. The patients with PSMA-avid lesion in the prostate underwent robotic arm-assisted PET-guided transgluteal biopsies. The degree of pain during the procedure, procedure-related complications and histopathology were evaluated.